FDA
-
-
-
-
-
-
-
Silence Therapeutics completes enrollment in phase 2 PV study
-
-
-
-
-
-
-
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
-
-
-
-
-
-
-
Mithra - Letter to Shareholders and Corporate Update
-
-
-
-
-
-
-
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
-
-
-
-
-
-
-
Silence Therapeutics Reports Full-year 2020 Results
335,353 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


